Webinar Series Introduction
Welcome to the Stroke Reduction with LAA Closure CME-accredited webinar series, which offers on-demand archives of past live webinars and announces upcoming activities. The activities highlight the experiences and insights of world-renowned multidisciplinary faculty experts on stroke risk reduction with LAA Closure and on optimal clinical decision-making strategies for improved patient care.
Upcoming Live Webinars |
Stroke Risk Reduction with LAA Closure: A Meta-Analysis of Randomized Trials
Date and Time
Monday, September 21, 2026 • 6:00 – 7:00 PM Eastern Time
This CME-accredited webinar features a multidisciplinary panel of experts who will thoroughly review an updated meta-analysis of randomized controlled trials comparing Left Atrial Appendage Closure (LAAC) with oral anticoagulation in patients with atrial fibrillation. The discussion will focus on efficacy and safety, including bleeding risks such as clinically relevant non-major bleeding, and on stroke characterization data. The faculty will evaluate how these results can inform personalized, patient-centered decisions by weighing the risks of stroke and bleeding. Attendees will have the opportunity to engage directly by submitting questions to the faculty during the live session.
Stroke Risk Reduction with LAA Closure: Shared Decision-Making Considerations
Coming November 2026
On-Demand Library |
Stroke Risk Reduction with LAA Closure: Clinical Indications and Patient Considerations
Activity Description
This CME-accredited on-demand webinar features a multidisciplinary faculty of experts who discuss the role of WATCHMAN therapy in reducing stroke risk. It offers a comprehensive review of recent clinical data, with a particular focus on the CHAMPION-AF trial presented at the ACC Scientific Sessions 2026. The panel evaluates how new data influence patient care and treatment choices and explores patient selection and clinical decision-making strategies through case reviews.
CHAMPION-AF Clinical Trial Results and Impact on Practice
Activity Description
The CME-accredited on-demand webinars include archives of three geo-targeted live broadcasts reviewing the CHAMPION-AF clinical trial, which was released at the ACC Scientific Sessions 2026 and published simultaneously in The New England Journal of Medicine. Each session features the late-breaking clinical trial presentation from the prospective, randomized, multi-center global study led by Principal Investigator Dr. Shephal Doshi. Additionally, each includes a unique moderator and panelists from multiple disciplines and regions of practice, who analyze the global impact of the results on healthcare systems in different regions and assess future directions.